12/02/2017
Neurogenx treatment has helped thousands of people suffering with CIPN. Unfortunately, most physicians still believe that treatments currently on the market are ineffective. Well, we are proving them wrong with our results. https://buff.ly/2AvUcbZ
“Neuropathy is a pretty pervasive problem; it can happen to patients with any type of cancer and be caused by many types of chemotherapy,” said Sarah Prinsloo, Ph.D., an assistant professor in the Department of Palliative, Rehabilitation, and Integrative Medicine. “And there aren’t a lot of effective treatments on the market for it.”
https://buff.ly/2AyhM7G
Testimonial Disclaimer: On average, patients who receive the NEUROGENX treatment experience an 87% reduction in symptoms, based on an April 2012 published medical study. Individual results may vary…